https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55179 Wed 24 Apr 2024 09:34:46 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:44380 product: the product being an active state of motivation whereas the process would include the antecedents that created that state. This hypothesis was tested by interviewing 47 university students immediately after normal lectures. Results showed that 89% had experienced an active state of motivation (the product phase) that was influenced by antecedents that included personal characteristics (e.g., self-efficacy, individual interest), temporal personal factors (mood, fatigue), and contextual factors (teacher enthusiasm and “interestingness”). It was concluded that process-product is a potentially useful framework for conceptualizing motivation.]]> Wed 12 Oct 2022 11:20:34 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29506 n = 19; 70%). Twenty-three studies targeted adults (17 showed significant health improvements) and four studies targeted children (two demonstrated significant health improvements). Twenty-one studies targeted physical activity (14 showed significant health improvements), 13 studies targeted diet (seven showed significant health improvements) and five studies targeted sedentary behaviour (two showed significant health improvements). More studies (n = 12; 63%) of those reporting significant effects detected between-group improvements in the health behaviour or related health outcomes, whilst fewer studies (n = 8; 42%) reported significant within-group improvements. A larger proportion of multi-component interventions (8 out of 13; 62%) showed significant between-group improvements compared to stand-alone app interventions (5 out of 14; 36%). Eleven studies reported app usage statistics, and three of them demonstrated that higher app usage was associated with improved health outcomes. Conclusions: This review provided modest evidence that app-based interventions to improve diet, physical activity and sedentary behaviours can be effective. Multi-component interventions appear to be more effective than stand-alone app interventions, however, this remains to be confirmed in controlled trials. Future research is needed on the optimal number and combination of app features, behaviour change techniques, and level of participant contact needed to maximise user engagement and intervention efficacy.]]> Wed 11 Apr 2018 16:16:34 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:15419 Wed 11 Apr 2018 14:54:08 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:14537 Wed 11 Apr 2018 14:02:42 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:22780 Wed 11 Apr 2018 11:03:40 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51990 Tue 26 Sep 2023 10:53:57 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51185 Thu 24 Aug 2023 14:37:48 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:17340 Thu 20 Sep 2018 15:06:33 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:10762 Sat 24 Mar 2018 08:13:54 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:10025 Sat 24 Mar 2018 08:12:18 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:18986 20% occurred in only one subject with AECOPD who was in GOLD category III. The decrease in percentage of FEV1 from baseline was greatest in the second stage of induction, and correlated with that of the final stage (r = 0.589; P = 0.01). The fall in FEV1 during induction increased with GOLD category (P < 0.05). Conclusions:  SI can be safely and successfully performed in patients with moderate to very severe chronic obstructive pulmonary disease who experience an exacerbation using this modified induction protocol. The early decrease in FEV1 can be used to predict the maximum fall.]]> Sat 24 Mar 2018 07:58:51 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:16425 Sat 24 Mar 2018 07:51:18 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29896 Sat 24 Mar 2018 07:29:55 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:4796 Sat 24 Mar 2018 07:20:40 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:41100 Mon 25 Jul 2022 10:38:22 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:33359 n = 427 kraal months) where lions (Panthera leo) frequently kill cattle. Monthly kraal use was 60% and was significantly influenced by kraal type, age, and shape. When used and maintained, kraals stopped livestock depredation. Due to poor maintenance, however, kraal age had a significant, negative influence on kraal use and effectiveness, compromising sustainability and cost-effectiveness. Fortified kraals built by a non-governmental organisation cost US$1322.36 per unit (n = 20) and mitigated a mean annual loss of $187.32. This suggests cost-recuperation after 7.0 years, or 2.3 times longer than observed kraal lifetime. Conversely, owner-built replicates cost $579.90 per unit (n = 4), recuperating investment after 3.1 years. Owner satisfaction was significantly higher for fortified kraals when compared with traditional kraals. However, owners of fortified kraals did not kraal their cattle more frequently than owners of traditional kraals. Regionally, the mean annual kraaling rate for 29 GPS-monitored cattle herds (n = 3360 nights) was 40%, leaving cattle vulnerable to depredation, and highlighting the importance of promoting vigilant herding together with kraaling to prevent losses. This combination could reduce regional livestock losses by 80%, or >$38,000 annually, however, kraal fortification alone does not provide a blanket solution to carnivore conflicts in Africa's agro-pastoral landscapes.]]> Mon 22 Feb 2021 16:11:52 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52515 Mon 16 Oct 2023 10:38:42 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:37948 Mon 05 Jul 2021 19:19:06 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55452 4 weeks are widely lacking. We evaluated the efficacy and safety of 8 weeks of treatment with the herbal combination product STW 5-II for patients with functional dyspepsia (FD) meeting Rome II criteria. We also conducted a post hoc analysis including patients meeting Rome IV criteria for FD and evaluated the effect of the G-protein beta 3 (GNB3) subunit polymorphism (C825T) on therapeutic response. Methods: This multicenter, placebo-controlled, double-blind study included 272 FD patients meeting Rome II criteria in the intention-to-treat cohort and 266 meeting Rome IV criteria. We used the validated Gastrointestinal Symptom Score (GIS) to assess GI symptoms, defining response rate as the proportion of patients with ≥50% GIS improvement in at least three of four assessments. Results: After 8 weeks, the response rate was significantly higher in the STW 5-II group versus placebo (61.2% vs 45.1%, P = 0.008). Mean GIS non-significantly improved with STW 5-II treatment (7.9 ± 4.41 vs 6.7 ± 4.91 with placebo; P = 0.07). In the Rome IV subgroup analysis, STW 5-II yielded a better response rate (P = 0.01) versus placebo and greater postprandial distress symptom improvement (P = 0.04) versus placebo. Safety parameters did not differ between groups, and GNB3 status was not linked with therapeutic response. Conclusion: STW 5-II is efficacious, with no observed safety signals at up to 8 weeks of treatment in patients with FD meeting Rome II or IV criteria.]]> Mon 03 Jun 2024 08:38:06 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46439 Fri 25 Nov 2022 15:28:35 AEDT ]]>